ketoconazole and atazanavir sulfate

ketoconazole has been researched along with atazanavir sulfate in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abel, S; Muirhead, GJ; Ridgway, CE; Russell, D; Taylor-Worth, RJ	1
Collins, C; Dickins, M; Hyland, R; Jones, B; Jones, H	1
Li, F; Lu, J; Ma, X; Wang, L	1
Chowan, GS; Desikan, S; Gautam, SS; Mandlekar, S; Padmanabhan, S; Saxena, A; Shah, D	1

Trials

1 trial(s) available for ketoconazole and atazanavir sulfate

Article	Year
Effects of CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers. British journal of clinical pharmacology, 2008, Volume: 65 Suppl 1 Topics: Adolescent; Anti-HIV Agents; Antifungal Agents; Atazanavir Sulfate; CCR5 Receptor Antagonists; Cyclohexanes; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Ketoconazole; Male; Maraviroc; Middle Aged; Oligopeptides; Pyridines; Saquinavir; Statistics as Topic; Triazoles	2008

Article

Year

Effects of CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers.

British journal of clinical pharmacology, 2008, Volume: 65 Suppl 1

Topics: Adolescent; Anti-HIV Agents; Antifungal Agents; Atazanavir Sulfate; CCR5 Receptor Antagonists; Cyclohexanes; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Ketoconazole; Male; Maraviroc; Middle Aged; Oligopeptides; Pyridines; Saquinavir; Statistics as Topic; Triazoles

2008

Other Studies

3 other study(ies) available for ketoconazole and atazanavir sulfate

Article	Year
Maraviroc: in vitro assessment of drug-drug interaction potential. British journal of clinical pharmacology, 2008, Volume: 66, Issue:4 Topics: Area Under Curve; Atazanavir Sulfate; Cyclohexanes; Cytochrome P-450 CYP3A; Drug Interactions; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Ketoconazole; Liver; Male; Maraviroc; Microsomes, Liver; Oligopeptides; Predictive Value of Tests; Pyridines; Ritonavir; Saquinavir; Triazoles	2008
CYP3A-mediated generation of aldehyde and hydrazine in atazanavir metabolism. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:3 Topics: Aldehydes; Animals; Atazanavir Sulfate; Biotransformation; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Enzyme Inhibitors; Feces; HIV Protease Inhibitors; Humans; Hydrazines; Ketoconazole; Metabolomics; Mice; Microsomes, Liver; Oligopeptides; Pyridines; Recombinant Proteins; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry	2011
Prediction of pH dependent absorption using in vitro, in silico, and in vivo rat models: Early liability assessment during lead optimization. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2015, Aug-30, Volume: 76 Topics: Administration, Oral; Animals; Atazanavir Sulfate; Chemistry, Pharmaceutical; Computer Simulation; Drug Discovery; Gastric Absorption; Gastric Acid; Gastric Mucosa; Humans; Hydrogen-Ion Concentration; Ketoconazole; Male; Models, Biological; Rats, Wistar; Solubility; Species Specificity	2015